The influence of immunization route, tissue microenvironment, and cytokine cell milieu on HIV-specific CD8+ T cells measured using Fluidigm Dynamic arrays

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Trivedi, Shubhanshi ^a   Ranasinghe, Charani ^a  

^a Biology and Environment   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; BETA1 INTEGRIN; BETA7 INTEGRIN; CD11B ANTIGEN; CD69 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR9; FIBRONECTIN RECEPTOR; GAMMA INTERFERON; GLYCOPROTEIN P 15095; GRANZYME; GRANZYME A; GRANZYME B; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTEGRIN; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; L SELECTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; P SELECTIN GLYCOPROTEIN LIGAND 1; PERFORIN; RIBOSOME PROTEIN; CYTOKINE;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL HOMING; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIMERIZATION; DRUG ADMINISTRATION ROUTE; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOREGULATION; MICROENVIRONMENT; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PEYER PATCH; PROTEIN EXPRESSION; ANIMAL; BAGG ALBINO MOUSE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; KNOCKOUT MOUSE; PROCEDURES;

MUS;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DRUG ADMINISTRATION ROUTES; FEMALE; GRANZYMES; HIV INFECTIONS; HIV-1; IMMUNITY, MUCOSAL; IMMUNIZATION; INTEGRINS; INTERLEUKIN-13; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PERFORIN; RNA, MESSENGER;

EID: 84929120178     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126487     Document Type: Article

References (50)

1. Belyakov IM, Ahlers JD, Nabel GJ, Moss B, Berzofsky JA. Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization. Virology. 2008; 381(1):106-15. Epub 2008/09/17. doi: 10.1016/j.virol.2008.08.019 PMID: 18793787.
2. Belyakov IM, Derby MA, Ahlers JD, Kelsall BL, Earl P, Moss B, et al. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. P Natl Acad Sci USA. 1998; 95(4):1709-14. doi: 10.1073/pnas.95.4.1709. WOS:000072115900064. PMID: 9465081
3. Eo SK, Gierynska M, Kamar AA, Rouse BT. Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules. Journal of immunology. 2001; 166(9):5473-9. PMID: 11313385.
4. Kozlowski PA, Cu-Uvin S, Neutra MR, Flanigan TP. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infection and immunity. 1997; 65(4):1387-94. Epub 1997/04/01. PMID: 9119478; PubMed Central PMCID: PMCPmc175144.
5. Kent SJ, Dale CJ, Ranasinghe C, Stratov I, De Rose R, Chea S, et al. Mucosally-administered humansimian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3. Vaccine. 2005; 23(42):5009-21. doi: 10.1016/j.vaccine.2005.05.032. ISI:000232265200006. PMID: 15985317
6. Ranasinghe C, Eyers F, Stambas J, Boyle DB, Ramshaw IA, Ramsay AJ. A comparative analysis of HIV-specific mucosal/systemic T cell immunity and avidity following rDNA/rFPV and poxvirus - poxvirus prime boost immunisations. Vaccine. 2011; 29(16):3008-20. doi: 10.1016/j.vaccine.2011.01.106 PMID: 21352941
7. Almeida JR, Price DA, Papagno L, Arkoub ZA, Sauce D, Bornstein E, et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med. 2007; 204(10):2473-85. Epub 2007/09/26. doi: jem.20070784 [pii] doi: 10.1084/jem.20070784 PMID: 17893201; PubMed Central PMCID: PMC2118466.
8. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006; 107(12):4781-9. Epub 2006/02/10. doi: 2005-12-4818 [pii] doi: 10.1182/blood-2005-12-4818 PMID: 16467198; PubMed Central PMCID: PMC1895811.
9. Ranasinghe C, Medveczky JC, Woltring D, Gao K, Thomson S, Coupar BE, et al. Evaluation of fowl-pox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1. Vaccine. 2006; 24(31-32):5881-95. Epub 2006/06/09. doi: S0264-410X(06)00456-7 [pii]. doi: 10.1016/j.vaccine.2006.04.023 PMID: 16759767.
10. Ranasinghe C, Turner SJ, McArthur C, Sutherland DB, Kim JH, Doherty PC, et al. Mucosal HIV-1 pox virus prime-boost immunization induces high-avidity CD8+ T cells with regime-dependent cytokine/granzyme B profiles. Journal of immunology. 2007; 178(4):2370-9. Epub 2007/02/06. doi: 178/4/2370 [pii]. PMID: 17277143.
11. Wijesundara DK, Ranasinghe C, Jackson RJ, Lidbury BA, Parish CR, Quah BJC. Use of an In Vivo FTA Assay to Assess the Magnitude, Functional Avidity and Epitope Variant Cross-Reactivity of T Cell Responses Following HIV-1 Recombinant Poxvirus Vaccination. PLoS ONE. 2014; 9(8):e105366. doi: 10.1371/journal.pone.0105366 PMID: 25170620
12. Ranasinghe C, Ramshaw IA. Immunisation route-dependent expression of IL-4/IL-13 can modulate HIV-specific CD8(+) CTL avidity. Eur J Immunol. 2009; 39(7):1819-30. Epub 2009/07/08. doi: 10.1002/eji.200838995 PMID: 19582753.
13. Masopust D, Vezys V,Wherry EJ, Barber DL, Ahmed R. Cutting edge: gut microenvironment promotes differentiation of a unique memory CD8 T cell population. Journal of immunology. 2006; 176(4):2079-83. Epub 2006/02/04. PMID: 16455963.
14. Takenaka S, McCormick S, Safroneeva E, Xing Z, Gauldie J. Influence of the tissue microenvironment on Toll-like receptor expression by CD11c+ antigen-presenting cells isolated from mucosal tissues. Clinical and Vaccine Immunology. 2009; 16(11):1615-23. doi: 10.1128/CVI.00216-09 PMID: 19776199
15. Baaten BJ, Cooper AM, Swain SL, Bradley LM. Location, location, location: the impact of migratory heterogeneity on T cell function. Frontiers in Immunology. 2013; 4. doi: 10.3389/fimmu.2013.00311
16. Hathaway LJ, Kraehenbuhl JP. The role of M cells in mucosal immunity. Cellular and molecular life sciences: CMLS. 2000; 57(2):323-32. Epub 2000/04/15. PMID: 10766026.
17. Neutra MR, Frey A, Kraehenbuhl JP. Epithelial M cells: gateways for mucosal infection and immunization. Cell. 1996; 86(3):345-8. Epub 1996/08/09. doi: S0092-8674(00)80106-3 [pii]. PMID: 8756716.
18. Mora JR, Bono MR, Manjunath N, Weninger W, Cavanagh LL, Rosemblatt M, et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature. 2003; 424(6944):88-93. Epub 2003/07/04. doi: 10.1038/nature01726 PMID: 12840763.
19. Stagg AJ, Kamm MA, Knight SC. Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin. Eur J Immunol. 2002; 32(5):1445-54. Epub 2002/05/01. doi: 10.1002/1521-4141(200205)32:5&1445::AID-IMMU1445&3.0.CO;2-E PMID: 11981833.
20. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. Retinoic acid imprints gut-homing specificity on T cells. Immunity. 2004; 21(4):527-38. Epub 2004/10/16. doi: 10.1016/j.immuni.2004.08.011 PMID: 15485630.
21. Jespers V, Harandi AM, Hinkula J, Medaglini D, Le Grand R, Stahl-Hennig C, et al. Assessment of mucosal immunity to HIV-1. Expert review of vaccines. 2010; 9(4):381-94. doi: 10.1586/erv.10.21 PMID: 20370549.
22. Kantele A, Zivny J, Hakkinen M, Elson CO, Mestecky J. Differential homing commitments of antigenspecific T cells after oral or parenteral immunization in humans. Journal of immunology. 1999; 162-(9):5173-7. Epub 1999/05/05. PMID: 10227989.
23. Cerwenka A, Morgan TM, Harmsen AG, Dutton RW. Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J Exp Med. 1999; 189(2):423-34. Epub 1999/01/20. PMID: 9892624; PubMed Central PMCID: PMC2192982.
24. Rose JR, Williams MB, Rott LS, Butcher EC, Greenberg HB. Expression of the mucosal homing receptor alpha4beta7 correlates with the ability of CD8+ memory T cells to clear rotavirus infection. J Virol. 1998; 72(1):726-30. Epub 1998/01/07. PMID: 9420279; PubMed Central PMCID: PMC109428.
25. Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nature reviews Immunology. 2006; 6(2):148-58. Epub 2006/02/24. doi: 10.1038/nri1777 PMID: 16491139.
26. Ogra PL, Faden H, Welliver RC. Vaccination strategies for mucosal immune responses. Clinical microbiology reviews. 2001; 14(2):430-45. Epub 2001/04/09. doi: 10.1128/cmr.14.2.430-445.2001 PMID: 11292646; PubMed Central PMCID: PMCPmc88982.
27. Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nature medicine. 2005; 11(4 Suppl): S45-53. Epub 2005/04/07. doi: 10.1038/nm1213 PMID: 15812489.
28. Ebert EC. Tumour necrosis factor-alpha enhances intraepithelial lymphocyte proliferation and migration. Gut. 1998; 42(5):650-5. Epub 1998/07/11. PMID: 9659158; PubMed Central PMCID: PMCPmc1727124.
29. Nolan T, Hands RE, Bustin SA. Quantification of mRNA using real-time RT-PCR. Nat Protocols. 2006; 1(3):1559-82. PMID: 17406449
30. Arsenio J, Kakaradov B, Metz PJ, Kim SH, Yeo GW, Chang JT. Early specification of CD8+ T lymphocyte fates during adaptive immunity revealed by single-cell gene-expression analyses. Nature immunology. 2014; 15(4):365-72. Epub 2014/03/04. doi: 10.1038/ni.2842 PMID: 24584088; PubMed Central PMCID: PMCPmc3968536.
31. Flatz L, Roychoudhuri R, Honda M, Filali-Mouhim A, Goulet JP, Kettaf N, et al. Single-cell gene-expression profiling reveals qualitatively distinct CD8 T cells elicited by different gene-based vaccines. Proc Natl Acad Sci U S A. 2011; 108(14):5724-9. Epub 2011/03/23. doi: 10.1073/pnas.1013084108 PMID: 21422297; PubMed Central PMCID: PMCPmc3078363.
32. Chattopadhyay PK, Gierahn TM, Roederer M, Love JC. Single-cell technologies for monitoring immune systems. Nature immunology. 2014; 15(2):128-35. doi: 10.1038/ni.2796 PMID: 24448570
33. Hamann A, Klugewitz K, Austrup F, Jablonski-Westrich D. Activation induces rapid and profound alterations in the trafficking of T cells. Eur J Immunol. 2000; 30(11):3207-18. Epub 2000/11/28. doi: 10.1002/1521-4141(200011)30:11<3207::aid-immu3207>3.0.co;2-l PMID: 11093136.
34. Galkina E, Tanousis K, Preece G, Tolaini M, Kioussis D, Florey O, et al. L-selectin shedding does not regulate constitutive T cell trafficking but controls the migration pathways of antigen-activated T lymphocytes. J Exp Med. 2003; 198(9):1323-35. Epub 2003/11/05. doi: 10.1084/jem.20030485 PMID: 14597735; PubMed Central PMCID: PMCPmc2194256.
35. Venturi GM, Tu L, Kadono T, Khan AI, Fujimoto Y, Oshel P, et al. Leukocyte Migration Is Regulated by L-Selectin Endoproteolytic Release. Immunity. 2003; 19(5):713-24. doi: 10.1016/S1074-7613(03)00295-4 PMID: 14614858
36. Sheasley-O'Neill SL, Brinkman CC, Ferguson AR, Dispenza MC, Engelhard VH. Dendritic cell immunization route determines integrin expression and lymphoid and nonlymphoid tissue distribution of CD8 T cells. Journal of immunology. 2007; 178(3):1512-22. Epub 2007/01/24. PMID: 17237400.
37. Campbell DJ, Butcher EC. Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues. J Exp Med. 2002; 195(1):135-41. Epub 2002/01/10. PMID: 11781372; PubMed Central PMCID: PMCPmc2196018.
38. Dudda JC, Simon JC, Martin S. Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin: role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets. Journal of immunology. 2004; 172(2):857-63. Epub 2004/01/07. PMID: 14707056.
39. Agace WW, Higgins JM, Sadasivan B, Brenner MB, Parker CM. T-lymphocyte-epithelial-cell interactions: integrin alpha(E)(CD103)beta(7), LEEP-CAM and chemokines. Current opinion in cell biology. 2000; 12(5):563-8. Epub 2000/09/09. PMID: 10978890.
40. Schon MP, Arya A, Murphy EA, Adams CM, Strauch UG, Agace WW, et al. Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. Journal of immunology. 1999; 162(11):6641-9. Epub 1999/06/03. PMID: 10352281.
41. Sigmundsdottir H, Butcher EC. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nature immunology. 2008; 9(9):981-7. Epub 2008/08/20. doi: 10.1038/ni.f.208 PMID: 18711435; PubMed Central PMCID: PMCPmc3171274.
42. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992; 69(1):11-25. PMID: 1555235.
43. Huleatt JW, Lefrançois L. β2 Integrins and ICAM-1 Are Involved in Establishment of the Intestinal Mucosal T Cell Compartment. Immunity. 1996; 5(3):263-73. doi: 10.1016/S1074-7613(00)80321-0 PMID: 8808681
44. Jackson RJ, Worley M, Trivedi S, Ranasinghe C. Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy. Vaccine. 2014; 20-(14):01136-0. Epub 2014/08/26. doi: 10.1016/j.vaccine.2014.08.023 PMID: 25151041.
45. Ranasinghe C, Trivedi S, Stambas J, Jackson RJ. Unique IL-13Ralpha2-based HIV-1 vaccine strategy to enhance mucosal immunity, CD8(+) T-cell avidity and protective immunity. Mucosal immunology. 2013; 6(6):1068-80. Epub 2013/02/14 06:00. doi: 10.1038/mi.2013.1 PMID: 23403475.
46. Chin YH, Cai JP, Xu XM. Tissue-specific homing receptor mediates lymphocyte adhesion to cytokine-stimulated lymph node high endothelial venule cells. Immunology. 1991; 74(3):478- 83. Epub 1991/11/01. PMID: 1769695; PubMed Central PMCID: PMCPmc1384643.
47. Wagers AJ, Waters CM, Stoolman LM, Kansas GS. Interleukin 12 and interleukin 4 control T cell adhesion to endothelial selectins through opposite effects on alpha1, 3-fucosyltransferase VII gene expression. J Exp Med. 1998; 188(12):2225-31. Epub 1998/12/22. PMID: 9858509; PubMed Central PMCID: PMCPmc2212430.
48. Lim SP, Leung E, Krissansen GW. The beta7 integrin gene (Itgb-7) promoter is responsive to TGF-beta1: defining control regions. Immunogenetics. 1998; 48(3):184-95. Epub 1998/07/31. PMID: 9683663.
49. Trivedi S, Jackson RJ, Ranasinghe C. Different HIV pox viral vector-based vaccines and adjuvants can induce unique antigen presenting cells that modulate CD8 T cell avidity. Virology. 2014; 468-470(0):479-89. doi: 10.1016/j.virol.2014.09.004
50. Xi Y, Day SL, Jackson RJ, Ranasinghe C. Role of novel type I interferon epsilon in viral infection and mucosal immunity. Mucosal immunology. 2012; 5(6):610-22. Epub 2012/05/24. doi: 10.1038/mi.2012.35 PMID: 22617838